Tag Archives: New €24 Million Investment Positions ShanX Medtech for Clinical Launch of Rapid AST Technology

ShanX Medtech Secures €24 Million to Fast Track Ultra Rapid Diagnostics Against Antimicrobial Resistance

(IN BRIEF) ShanX Medtech, a spin-off from Eindhoven University of Technology, has raised €24 million in combined public and private funding to accelerate the development of its ultra-rapid antimicrobial susceptibility testing platform. The financing includes an oversubscribed €15 million seed … Read the full press release